BRPI0715360B8 - método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição - Google Patents

método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição

Info

Publication number
BRPI0715360B8
BRPI0715360B8 BRPI0715360A BRPI0715360A BRPI0715360B8 BR PI0715360 B8 BRPI0715360 B8 BR PI0715360B8 BR PI0715360 A BRPI0715360 A BR PI0715360A BR PI0715360 A BRPI0715360 A BR PI0715360A BR PI0715360 B8 BRPI0715360 B8 BR PI0715360B8
Authority
BR
Brazil
Prior art keywords
producing
protein
recombinant
composition
meningococcal
Prior art date
Application number
BRPI0715360A
Other languages
English (en)
Inventor
Willie Sun Wei-Qiang
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0715360A2 publication Critical patent/BRPI0715360A2/pt
Publication of BRPI0715360B1 publication Critical patent/BRPI0715360B1/pt
Publication of BRPI0715360B8 publication Critical patent/BRPI0715360B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição. apresentam-se métodos para a produção de proteínas, por exemplo, proteínas 2086 meningocócícas recombinantes, usando fermentação por batelada alimentada com entrada contínua de um indutor depois de se atingir um parâmetro de limiar e, opcionalmente, a entrada contínua de uma fonte de carbono, por exemplo, uma entrada a taxa constante, para melhorar os rendimentos de proteína, assim como composições de proteínas de alta densidade e composições para uso nos métodos da presente invenção.
BRPI0715360A 2006-07-27 2007-07-21 método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição BRPI0715360B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83347906P 2006-07-27 2006-07-27
US833,479 2006-07-27
PCT/US2007/016917 WO2008013943A2 (en) 2006-07-27 2007-07-21 High-cell density fed-batch fermentation process for producing recombinant protein

Publications (3)

Publication Number Publication Date
BRPI0715360A2 BRPI0715360A2 (pt) 2013-06-18
BRPI0715360B1 BRPI0715360B1 (pt) 2021-01-19
BRPI0715360B8 true BRPI0715360B8 (pt) 2022-01-04

Family

ID=38982103

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715360A BRPI0715360B8 (pt) 2006-07-27 2007-07-21 método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição

Country Status (20)

Country Link
US (3) US8632995B2 (pt)
EP (2) EP2061897B1 (pt)
JP (2) JP2009544321A (pt)
KR (1) KR101419958B1 (pt)
CN (2) CN101535493A (pt)
AU (1) AU2007277081B2 (pt)
BR (1) BRPI0715360B8 (pt)
CA (1) CA2657135C (pt)
DK (1) DK2061897T3 (pt)
ES (1) ES2788001T3 (pt)
HK (1) HK1217969A1 (pt)
HU (1) HUE048973T2 (pt)
IL (1) IL196496A (pt)
MX (1) MX2009000813A (pt)
PL (1) PL2061897T3 (pt)
PT (1) PT2061897T (pt)
RU (1) RU2451070C2 (pt)
SG (1) SG174013A1 (pt)
SI (1) SI2061897T1 (pt)
WO (1) WO2008013943A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
HUE048973T2 (hu) 2006-07-27 2020-09-28 Wyeth Llc Nagy sejtsûrûségû, rátáplálásos-szakaszos fermentáló eljárás rekombináns fehérje elõállítására
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
EP3831406B1 (en) 2010-08-23 2024-06-05 Wyeth LLC Stable formulations of neisseria meningitidis rlp2086 antigens
AU2011300409B2 (en) 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
WO2012104176A1 (en) * 2011-01-31 2012-08-09 Novozymes A/S Use of browned glucose as a feed substrate
MX351993B (es) 2012-03-09 2017-11-03 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas.
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
EP2825633B1 (en) * 2012-03-12 2019-03-06 Hanmi Science Co., Ltd. Method of culturing e. coli cells for high density
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
MX369534B (es) 2013-09-08 2019-11-11 Pfizer Composiciones de neisseria meningitidis y sus metodos.
RU2561467C1 (ru) * 2014-04-24 2015-08-27 Сергей Михайлович Юдин Способ получения препарата для повышения мясной и молочной продуктивности сельскохозяйственных животных (варианты) и препарат, полученный на его основе
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10322304B2 (en) * 2015-01-29 2019-06-18 Sandy Kronenberg Nasal air filter
RU2723045C2 (ru) 2015-02-19 2020-06-08 Пфайзер Инк. Композиции neisseria meningitidis и способы их получения
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP7010961B2 (ja) 2017-01-31 2022-02-10 ファイザー・インク 髄膜炎菌組成物およびその方法
WO2021087404A1 (en) * 2019-10-30 2021-05-06 Future Fields Cellular Agriculture and Research LTD. Method for producing recombinant proteins in insects
CN117510596A (zh) * 2023-11-13 2024-02-06 中山迈托姆生物技术有限公司 一种大肠杆菌高密度表达犬瘟热抗原的发酵工艺及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414329A (en) * 1980-01-15 1983-11-08 Phillips Petroleum Company Biochemical conversions by yeast fermentation at high cell densities
GB8516415D0 (en) * 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5672502A (en) * 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5681718A (en) 1986-03-14 1997-10-28 Celltech Limited Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
RU2111246C1 (ru) * 1992-06-03 1998-05-20 Дербышев Виктор Викторович Способ получения биомассы аэробнорастущих микроорганизмов
AUPM772494A0 (en) 1994-08-30 1994-09-22 Austin Research Institute, The Improvements in production of proteins in host cells
AR005035A1 (es) * 1995-12-11 1999-04-07 Merck Patent Ges Mit Beschränkter Haftung Procedimiento para preparar proteinas recombinantes en e. coli, mediante fermentacion con gran concentracion de celulas.
AU722624B2 (en) 1996-09-06 2000-08-10 Trustees Of The University Of Pennsylvania, The An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
US6692961B1 (en) 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
KR20020043254A (ko) * 1999-10-29 2002-06-08 스타르크, 카르크 L-판토락톤 가수분해 효소 및 d-판토락톤의 제조 방법
MXPA03004324A (es) * 2000-11-20 2004-01-26 Cargill Inc Acido 3-hidroxipropionico y otros compuestos organicos.
FI120310B (fi) 2001-02-13 2009-09-15 Valtion Teknillinen Parannettu menetelmä erittyvien proteiinien tuottamiseksi sienissä
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
CN1504575A (zh) * 2002-12-03 2004-06-16 怀德生技化学股份有限公司 以左旋阿拉伯糖诱导t7表达系统的控制方法
CA2507817C (en) * 2002-12-13 2014-04-22 Zymogenetics, Inc. Il-21 production in prokaryotic hosts
DE10305774A1 (de) * 2003-02-06 2004-08-26 Consortium für elektrochemische Industrie GmbH Verfahren zur fermentativen Herstellung von L-Methionin
WO2004094596A2 (en) 2003-04-16 2004-11-04 Wyeth Holdings Corporation Novel immunogenic compositions for the prevention and treatment of meningococcal disease
CN100384998C (zh) * 2003-11-11 2008-04-30 浙江大学 重组鹅白细胞介素-2蛋白的制备方法及其用途
US8227241B2 (en) * 2004-03-12 2012-07-24 Unigene Laboratories, Inc. Bacterial host cell for the direct expression of peptides
HUE048973T2 (hu) 2006-07-27 2020-09-28 Wyeth Llc Nagy sejtsûrûségû, rátáplálásos-szakaszos fermentáló eljárás rekombináns fehérje elõállítására

Also Published As

Publication number Publication date
AU2007277081A1 (en) 2008-01-31
BRPI0715360B1 (pt) 2021-01-19
EP2061897B1 (en) 2020-03-25
MX2009000813A (es) 2009-02-03
KR20090034375A (ko) 2009-04-07
EP3705579A1 (en) 2020-09-09
IL196496A0 (en) 2011-08-01
JP2014064583A (ja) 2014-04-17
EP2061897A4 (en) 2012-03-07
WO2008013943A3 (en) 2009-04-02
CA2657135A1 (en) 2008-01-31
RU2008152445A (ru) 2010-09-10
ES2788001T3 (es) 2020-10-20
PL2061897T3 (pl) 2020-09-07
US9279000B2 (en) 2016-03-08
RU2451070C2 (ru) 2012-05-20
CN101535493A (zh) 2009-09-16
US10301663B2 (en) 2019-05-28
US20160289725A1 (en) 2016-10-06
AU2007277081B2 (en) 2014-02-06
JP5925175B2 (ja) 2016-05-25
US8632995B2 (en) 2014-01-21
CA2657135C (en) 2016-03-15
KR101419958B1 (ko) 2014-07-16
SG174013A1 (en) 2011-09-29
US20140113329A1 (en) 2014-04-24
BRPI0715360A2 (pt) 2013-06-18
US20080026425A1 (en) 2008-01-31
EP2061897A2 (en) 2009-05-27
WO2008013943A2 (en) 2008-01-31
PT2061897T (pt) 2020-05-08
JP2009544321A (ja) 2009-12-17
DK2061897T3 (da) 2020-06-02
HUE048973T2 (hu) 2020-09-28
IL196496A (en) 2016-05-31
CN105463045A (zh) 2016-04-06
HK1217969A1 (zh) 2017-01-27
SI2061897T1 (sl) 2020-07-31

Similar Documents

Publication Publication Date Title
BRPI0715360B8 (pt) método para a produção de uma proteína recombinante; método para a produção de uma proteína 2086 meningocócica recombinante (p2086); e composição
WO2019126634A3 (en) Targeted integration of nucleic acids
ATE473278T1 (de) Verfahren und zusammensetzungen zur herstellung rekombinanter proteine unter verwendung eines gens für trna
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
BR112017025614A2 (pt) método para produzir glicosídeo de esteviol e composição
ECSP11011502A (es) Anticuerpos contra el factor de crecimiento nervioso (ngf) con estabilidad in vivo mejorada
BR112013003361B8 (pt) Anticorpo, composição, conjugado de anticorpo,formulação farmacêutica e uso do anticorpo
AR070716A1 (es) Metodos para modificar el punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en la region de determinacion de la complementariedad (cdr)
WO2009002456A3 (en) Methods and compositions relating to progenitor cells
BR112013000515A2 (pt) método para prodduzir um composição de fator von willebrand recombinante (rvwf), sobrenadante de cultura de célula, e, composição do fator von willebrand recombinante (rvwf)
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
BR112013027229A2 (pt) composições que se relacionam a uma toxina de clostridium difficile mutante e métodos para as mesmas
BRPI0910368B8 (pt) uso de um ou mais biointensificadores, composição para o uso de um ou mais intensificadores escolhidos entre biointensificadores e fotointensificadores e colírio para o uso de um ou mais intensificadores escolhidos entre biointensificadores e fotointensificadores
MX2009010492A (es) Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped.
MX2011006846A (es) Virus de fiebre porcina clasico recombinante (csfv) comprendiendo una proteina e2 modificada y metodos para generar dicho csfv.
IL196893A0 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
BR112012017345A2 (pt) "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)"
EA201690946A1 (ru) Мутанты fgf21 и их применение
CR20120026A (es) Construcciones novedosas de proteína del virus de papiloma humano (hpv) y su uso en la prevención de la enfermedad por el hpv
BR112012020628A2 (pt) fotoiniciador de éter polialquílico, uso de um fotoiniciador de éter polialquílico, método para curar uma composição de matriz, e, composição de matriz
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
BRPI0514074A (pt) aperfeiçoamentos em composições em bloco para lavatório
EA202091349A1 (ru) Способы культивирования клеток
UA91551C2 (ru) Композиция сложных алкиловых эфиров, способ ее получения и применения как биодизельного топлива
MY180183A (en) Methods and compositions for preventing norleucine misincorporation into proteins

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2611 DE 19/01/2021 QUANTO AO INVENTO.